GB9819272D0 - Microparticles - Google Patents

Microparticles

Info

Publication number
GB9819272D0
GB9819272D0 GBGB9819272.7A GB9819272A GB9819272D0 GB 9819272 D0 GB9819272 D0 GB 9819272D0 GB 9819272 A GB9819272 A GB 9819272A GB 9819272 D0 GB9819272 D0 GB 9819272D0
Authority
GB
United Kingdom
Prior art keywords
microparticles
therapeutic agent
agent
spray
suspension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9819272.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Quadrant Holdings Cambridge Ltd
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10838317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB9819272(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Andaris Ltd filed Critical Andaris Ltd
Priority to GBGB9819272.7A priority Critical patent/GB9819272D0/en
Publication of GB9819272D0 publication Critical patent/GB9819272D0/en
Priority to CN99810476A priority patent/CN1315854A/zh
Priority to ES04075082T priority patent/ES2301929T3/es
Priority to EP04075082A priority patent/EP1410792B1/de
Priority to IL14132399A priority patent/IL141323A0/xx
Priority to CA002342206A priority patent/CA2342206C/en
Priority to DE69938201T priority patent/DE69938201T2/de
Priority to MXPA01002323A priority patent/MXPA01002323A/es
Priority to PCT/GB1999/002930 priority patent/WO2000013668A1/en
Priority to JP2000568477A priority patent/JP2002524411A/ja
Priority to ES99943130T priority patent/ES2223181T3/es
Priority to DK99943130T priority patent/DK1107737T3/da
Priority to BR9913456-0A priority patent/BR9913456A/pt
Priority to AT04075082T priority patent/ATE386507T1/de
Priority to AT99943130T priority patent/ATE265204T1/de
Priority to AU56407/99A priority patent/AU5640799A/en
Priority to DE69916856T priority patent/DE69916856T2/de
Priority to EP99943130A priority patent/EP1107737B1/de
Priority to US09/797,181 priority patent/US20020197325A1/en
Priority to US10/902,464 priority patent/US20050002870A1/en
Priority to JP2005278375A priority patent/JP2006096755A/ja
Priority to US11/540,720 priority patent/US20070026081A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
GBGB9819272.7A 1998-09-03 1998-09-03 Microparticles Ceased GB9819272D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
GBGB9819272.7A GB9819272D0 (en) 1998-09-03 1998-09-03 Microparticles
DE69916856T DE69916856T2 (de) 1998-09-03 1999-09-03 Micropartikeln zur verwendung in nadellosen injektion
EP99943130A EP1107737B1 (de) 1998-09-03 1999-09-03 Micropartikeln zur verwendung in nadellosen injektion
JP2000568477A JP2002524411A (ja) 1998-09-03 1999-09-03 微粒子
BR9913456-0A BR9913456A (pt) 1998-09-03 1999-09-03 Micropartìculas
EP04075082A EP1410792B1 (de) 1998-09-03 1999-09-03 Mikropartikel
IL14132399A IL141323A0 (en) 1998-09-03 1999-09-03 Microparticles
CA002342206A CA2342206C (en) 1998-09-03 1999-09-03 Microparticles
DE69938201T DE69938201T2 (de) 1998-09-03 1999-09-03 Mikropartikel
MXPA01002323A MXPA01002323A (es) 1998-09-03 1999-09-03 Microparticulas.
PCT/GB1999/002930 WO2000013668A1 (en) 1998-09-03 1999-09-03 Microparticles
CN99810476A CN1315854A (zh) 1998-09-03 1999-09-03 微粒
ES99943130T ES2223181T3 (es) 1998-09-03 1999-09-03 Microparticulas para uso en la inyeccion sin agujas.
DK99943130T DK1107737T3 (da) 1998-09-03 1999-09-03 Mikropartikler til anvendelse ved nålelös injektion
ES04075082T ES2301929T3 (es) 1998-09-03 1999-09-03 Microparticulas.
AT04075082T ATE386507T1 (de) 1998-09-03 1999-09-03 Mikropartikel
AT99943130T ATE265204T1 (de) 1998-09-03 1999-09-03 Micropartikeln zur verwendung in nadellosen injektion
AU56407/99A AU5640799A (en) 1998-09-03 1999-09-03 Microparticles
US09/797,181 US20020197325A1 (en) 1998-09-03 2001-03-02 Microparticles
US10/902,464 US20050002870A1 (en) 1998-09-03 2004-07-30 Microparticles
JP2005278375A JP2006096755A (ja) 1998-09-03 2005-09-26 微粒子
US11/540,720 US20070026081A1 (en) 1998-09-03 2006-10-02 Microparticles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9819272.7A GB9819272D0 (en) 1998-09-03 1998-09-03 Microparticles

Publications (1)

Publication Number Publication Date
GB9819272D0 true GB9819272D0 (en) 1998-10-28

Family

ID=10838317

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9819272.7A Ceased GB9819272D0 (en) 1998-09-03 1998-09-03 Microparticles

Country Status (15)

Country Link
US (3) US20020197325A1 (de)
EP (2) EP1410792B1 (de)
JP (2) JP2002524411A (de)
CN (1) CN1315854A (de)
AT (2) ATE386507T1 (de)
AU (1) AU5640799A (de)
BR (1) BR9913456A (de)
CA (1) CA2342206C (de)
DE (2) DE69916856T2 (de)
DK (1) DK1107737T3 (de)
ES (2) ES2223181T3 (de)
GB (1) GB9819272D0 (de)
IL (1) IL141323A0 (de)
MX (1) MXPA01002323A (de)
WO (1) WO2000013668A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002538195A (ja) * 1999-03-08 2002-11-12 パウダージェクト リサーチ リミテッド 生物活性化合物の持続放出用の無針注射器を使用する微粒子製剤の送達
US8771740B2 (en) * 1999-12-20 2014-07-08 Nicholas J. Kerkhof Process for producing nanoparticles by spray drying
DE10045521A1 (de) 2000-03-31 2001-10-04 Roche Diagnostics Gmbh Nukleinsäureamplifikationen
WO2002058670A1 (en) * 2001-01-25 2002-08-01 Euroceltique S.A. Local anesthetic, and method of use
WO2002100380A1 (en) * 2001-06-08 2002-12-19 Powderject Vaccines, Inc. Production of hard, dense particles
WO2003037303A1 (en) 2001-11-01 2003-05-08 Nektar Therapeutics Spray drying methods and compositions thereof
US9339459B2 (en) 2003-04-24 2016-05-17 Nektar Therapeutics Particulate materials
JP2007508240A (ja) * 2003-07-22 2007-04-05 バクスター・インターナショナル・インコーポレイテッド 低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
JP4210231B2 (ja) * 2004-03-25 2009-01-14 株式会社資生堂 皮膚のシワを改善する美容方法及びシワ改善具
US8728525B2 (en) 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
CA2603031A1 (en) * 2005-03-31 2006-10-05 Rafael Armament Development Authority Ltd. Apparatus for treating particles and liquids by ultrasound
CN101272848B (zh) * 2005-07-28 2013-03-13 Isp投资有限公司 改进喷雾干燥的粉末和颗粒材料性质的方法，以及由此生产的产品
AU2007208998A1 (en) * 2006-01-27 2007-08-02 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin A method of producing porous microparticles
MX2009001226A (es) 2006-08-04 2009-03-20 Baxter Int Composicion basada en microesferas para prevenir y/o revertir la diabetes autoinmune de nuevo inicio.
DE202006018609U1 (de) 2006-08-29 2007-05-16 Euro-Celtique S.A. Verwendung von Opioidformulierungen in nadellosen Vorrichtungen zur Medikamentenverabreichung
US20080085315A1 (en) * 2006-10-10 2008-04-10 John Alfred Doney Amorphous ezetimibe and the production thereof
WO2008076780A2 (en) * 2006-12-14 2008-06-26 Isp Investments Inc. Amorphous valsartan and the production thereof
US8613946B2 (en) * 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
EP2125938A2 (de) * 2007-01-26 2009-12-02 Isp Investments Inc. Verfahren zur herstellung einer formulierung für sprühgetrocknete produkte
ITMI20080807A1 (it) 2008-05-05 2009-11-06 Antibioticos Spa Procedimento per la preparazione di tigeciclina in forma amorfa
US8323685B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US8323615B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8367427B2 (en) 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
CN101732259B (zh) * 2009-12-29 2012-08-29 广东药学院 壳聚糖微米粒及其制备方法和应用
US9135998B2 (en) * 2010-11-09 2015-09-15 Micron Technology, Inc. Sense operation flags in a memory device
EP2898894A1 (de) 2014-01-27 2015-07-29 LTS LOHMANN Therapie-Systeme AG Nano-in-mikro-Teilchen zur intradermalen Verabreichung
CN111886031B (zh) * 2018-01-10 2022-10-14 G2G生物公司 含胶原蛋白肽的聚己内酯微球填充物及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3937668A (en) * 1970-07-15 1976-02-10 Ilse Zolle Method for incorporating substances into protein microspheres
CA1077842A (en) * 1975-10-09 1980-05-20 Minnesota Mining And Manufacturing Company Albumin medicament carrier system
US4247406A (en) * 1979-04-23 1981-01-27 Widder Kenneth J Intravascularly-administrable, magnetically-localizable biodegradable carrier
US4349530A (en) * 1980-12-11 1982-09-14 The Ohio State University Implants, microbeads, microcapsules, preparation thereof and method of administering a biologically-active substance to an animal
US4357254A (en) * 1981-01-12 1982-11-02 Chemical Sciences, Inc. Cleaning composition
FR2505657A1 (fr) * 1981-05-13 1982-11-19 Pasteur Institut Perfectionnements apportes aux agents de stabilisation de virus vivants pour la preparation de vaccins, et vaccins stabilises contenant lesdits agents de stabilisation
US5707644A (en) * 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
FR2663224B1 (fr) * 1990-06-14 1995-01-20 Applicationes Farmaceuticas Sa Forme galenique parenterale.
WO1994008576A1 (en) * 1992-10-16 1994-04-28 Glaxo Group Limited Taste-masking compositions of ranitidine
TW360548B (en) * 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
US5899880A (en) * 1994-04-08 1999-05-04 Powderject Research Limited Needleless syringe using supersonic gas flow for particle delivery
ATE177944T1 (de) * 1994-06-15 1999-04-15 Dumex Ltd As Pellets
IT1274879B (it) * 1994-08-03 1997-07-25 Saitec Srl Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
GB9502879D0 (en) * 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
KR100201352B1 (ko) * 1995-03-16 1999-06-15 성재갑 단일주사 백신 제형
US5922253A (en) * 1995-05-18 1999-07-13 Alkermes Controlled Therapeutics, Inc. Production scale method of forming microparticles
US6117449A (en) * 1996-03-22 2000-09-12 Bio-Sphere Technology, Inc. Method for inducing a systemic immune response to a hepatitis antigen
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
GB9612629D0 (en) * 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery

Also Published As

Publication number Publication date
ATE386507T1 (de) 2008-03-15
EP1107737A1 (de) 2001-06-20
DE69916856T2 (de) 2005-04-21
BR9913456A (pt) 2001-07-24
IL141323A0 (en) 2002-03-10
US20050002870A1 (en) 2005-01-06
US20070026081A1 (en) 2007-02-01
DE69916856D1 (de) 2004-06-03
CN1315854A (zh) 2001-10-03
EP1410792B1 (de) 2008-02-20
EP1410792A1 (de) 2004-04-21
US20020197325A1 (en) 2002-12-26
EP1410792A8 (de) 2004-12-29
CA2342206A1 (en) 2000-03-16
ES2301929T3 (es) 2008-07-01
ATE265204T1 (de) 2004-05-15
MXPA01002323A (es) 2002-05-08
AU5640799A (en) 2000-03-27
JP2002524411A (ja) 2002-08-06
DK1107737T3 (da) 2004-08-02
EP1107737B1 (de) 2004-04-28
WO2000013668A1 (en) 2000-03-16
DE69938201D1 (de) 2008-04-03
JP2006096755A (ja) 2006-04-13
DE69938201T2 (de) 2009-02-12
CA2342206C (en) 2006-12-12
ES2223181T3 (es) 2005-02-16

Similar Documents

Publication Publication Date Title
IL141323A0 (en) Microparticles
NZ505408A (en) Magnetically responsive composition, comprising ferrocarbon and a biologically active substance
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
BG102999A (en) New 2,3-diasubstituted-4-(3h)-quinazolinons
SG75091A1 (en) Process ii
PL346904A1 (en) Pharmaceutical agents for the treatment of parkinson's disease, adhd and microadenomas
NZ330360A (en) 5'-deoxy-cytidine derivatives, their manufacture and use as antitumoral agents
ZA988095B (en) New peptide mimetics for the treatment of bone metabolic disorders, methods for their production, and drugs containing these compounds.
BG105204A (en) Salts of paroxetine
HUP0401577A3 (en) Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
HUP0200679A2 (en) Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients
HUP0004386A3 (en) Methylenebisphosphonic acid derivatives, process for producing them and medicaments containing the same as active agent
HK1027825A1 (en) Use of arylguanidinium xanthogenates as vulcanization accelerators and process for the production thereof.
HK1039635B (zh) 一種新的谷氨酰胺酶及其基因和生產方法
GB2352450B (en) Method for producing of 2,3-dimethylbutene-1 and 2,3-dimethylbutene-2
EP1371732A4 (de) Fusionsprotein mit beta-1,2-n-acetylglucosaminyl-transferase-ii-aktivität und herstellungsverfahren dafür
YU17002A (sh) Upotreba deksrazoksana u lečenju psorijaze
DE69829174D1 (de) Exprimierung eines modifiziertem "foamy virus envelope protein" (hüllenprotein)
IVOLUME of SUciences
WO2001019358A3 (en) Use dexrazoxane for treating psoriasis
SI1165596T1 (en) 14,15-alpha-methylene equilenine derivatives, methods for producing the same and medicaments containing them
ZA200102029B (en) Pharmaceutical agents for the treatment of Parkinson's disease, ADHD and microadenomas.
ITMO930055A0 (it) "metodo per l'agglomerazione di polveri, o granuli,particolarmente per i settori alimentare,chimico o farmaceutico"
ZA99220B (en) Triazepinones, process for their preparation and their therapeutic application.

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)